Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 62 of 518 for:    hepatitis b | Open Studies

Thousand Asian American Study (TAAS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of California, Davis
Sponsor:
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT02596438
First received: October 19, 2015
Last updated: May 10, 2016
Last verified: May 2016
  Purpose
The "Thousand Asian American Study" or "TAAS" aims to test 2,000 foreign-born and children of foreign born Asian Americans residing in Sacramento county residents for HBV and (2) counsel at least 90% of those whose screening results are positive for HBV.

Condition Intervention
Hepatitis B
Other: Hepatitis B

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Target Follow-Up Duration: 6 Months
Official Title: Thousand Asian American Study (TAAS)

Resource links provided by NLM:


Further study details as provided by University of California, Davis:

Primary Outcome Measures:
  • Number of patients or adult children of patients born in Hepatitis B endemic countries (rate of 2% or higher) getting screened for hepatitis B. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Number of patients that are hepatitis B positive that receive counseling regarding their infection. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 2000
Study Start Date: October 2012
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Asian Americans
Foreign born or children of foreign born Asian American from Hepatitis B endemic areas residing in Sacramento, CA.
Other: Hepatitis B
Hepatitis B Surface Antigen, Hepatitis B Surface Antibody and Hepatitis B Core AB, Total Testing

Detailed Description:
The "Thousand Asian American Study" or "TAAS" aims to better understand the factors associated with testing for hepatitis B viral (HBV) testing among foreign-born Asian and African adult residents of Sacramento county, characteristics of those infected with HBV, and the efficacy of follow-up and linkage to care for those infected with HBV, and develop a research platform for future studies. Thus, what the investigators want to do is 1) test 2000 foreign-born Sacramento county residents for HBV and (2) counsel at least 90% of those whose screening results are positive for HBV. The investigators want to better characterize factors associated with HBV testing and factors that may differentiate those determined to be free of infection, infected with HBV, and those with resulting primary liver cancer.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Asian Americans residing in Sacramento, CA who are 18 years of age and older.
Criteria

Inclusion Criteria:

  • All foreign-born Asians and any foreign-born adults born in CDC-defined high to intermediate endemic areas residing in Sacramento County, California.

Exclusion Criteria:

  • Individuals who have been previously serologically tested for Hepatitis B (self-reported).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02596438

Contacts
Contact: Julie Dang, MPH 916-734-5222 jtdang@ucdavis.edu
Contact: Moon S. Chen Jr., PhD 916-734-1191 mschenjr@ucdavis.edu

Locations
United States, California
University of California, Davis Comprehensive Cancer Center Recruiting
Sacramento, California, United States, 95817
Contact: Julie Dang, MPH    916-734-5222    jtdang@ucdavis.edu   
Principal Investigator: Moon S Chen Jr., PhD, MPH         
Sponsors and Collaborators
University of California, Davis
Investigators
Principal Investigator: Moon S Chen Jr., PhD UC Davis Comprehensive Cancer Center
  More Information

Responsible Party: University of California, Davis
ClinicalTrials.gov Identifier: NCT02596438     History of Changes
Other Study ID Numbers: 388325 
Study First Received: October 19, 2015
Last Updated: May 10, 2016
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hepatitis B
Hepadnaviridae Infections
DNA Virus Infections
Virus Diseases
Hepatitis, Viral, Human
Hepatitis
Liver Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on September 30, 2016